What is an EGFR mutation in lung cancer, and why does it matter for treatment?
According to the U.S. National Cancer Institute (NCI), EGFR (epidermal growth factor receptor) is a protein found on certain cells that binds epidermal growth factor and is involved in cell signaling pathways that control cell division and survival. NCI explains that mutations (changes) in the EGFR gene can cause EGFR proteins to be made in higher-than-normal amounts on some cancer cells, causing those cells to divide more rapidly. This matters for treatment because EGFR is a type of receptor tyrosine kinase, and drugs that block EGFR proteins are being used to treat some cancers. Checking a tumor for such targets — biomarker testing — helps determine whether a targeted therapy may be an option. This is general information, not personal medical advice.
Last updated:
Related questions
- What does HER2-positive mean in breast cancer?
- What does PD-L1 mean in cancer immunotherapy?
- What is a BRCA gene mutation and which cancers is it linked to?
- What is DCIS (ductal carcinoma in situ)?
- What is the difference between small cell and non-small cell lung cancer?
- What is triple-negative breast cancer?